Acute Haemodynamic Impact of an IV Glucose-Injection

This study has been withdrawn prior to enrollment.
Information provided by:
University Hospital, Ghent Identifier:
First received: January 23, 2007
Last updated: April 9, 2009
Last verified: April 2009

Patients with peritoneal dialysis will be administered an IV glucose-injection to evaluate the haemodynamic impact of this injection. The patients will be matched with healthy volunteers.

Condition Intervention Phase
Peritoneal Dialysis
Drug: Administration of an IV glucose-injection
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Acute Haemodynamic Impact of an IV Glucose-Injection

Resource links provided by NLM:

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Haemodynamic parameters
  • Glycemia

Estimated Enrollment: 20

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • > 18 years old
  • Stable clinical condition
  • Either peritoneal dialysis (at least one month) either matched healthy subject

Exclusion Criteria:

  • Heart Failure
  • Diabetes requiring insulin treatment
  Contacts and Locations
Please refer to this study by its identifier: NCT00426114

Sponsors and Collaborators
University Hospital, Ghent
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: Wim Van Biesen, University Hospital Ghent Identifier: NCT00426114     History of Changes
Other Study ID Numbers: 2007/016
Study First Received: January 23, 2007
Last Updated: April 9, 2009
Health Authority: Belgium: Federal Agency for Medicinal Products and Health Products processed this record on April 17, 2014